The 2020 Technology Showcase welcomed more than 300 viewers for half a day of presentations and panels on technology commercialization and collaboration. The annual event once again highlighted the capabilities of the Frederick National Laboratory for Cancer Research, National Cancer Institute, and greater Frederick region—but this year, with its novel virtual format, it reached new audiences.

The fourth annual Technology Showcase is making a big pivot this year, moving to an entirely virtual event on September 9, 2020. Although the move was made out of necessity, it also offers exciting new opportunities to reach more partners and licensees beyond Frederick, Md.

Frederick has become a key player in biomedical research. That was the clear message from the third annual Technology Showcase, hosted by the National Cancer Institute (NCI) and the Frederick National Laboratory for Cancer Research. As usual, the event highlighted the numerous technologies developed by NCI and FNL scientists that are available to external groups for licensing and partnership. But this year, it also showcased the strength of the region.

Next month, the annual Technology Showcase will return to the Frederick National Laboratory for Cancer Research. The event attracts research innovators and business professionals who wish to learn about advanced technologies being developed at the National Cancer Institute and Frederick National Laboratory.

Before a crowded auditorium of science and business professionals at the Frederick National Laboratory for Cancer Research’s Advanced Technology Research Facility (ATRF), Joost Oppenheim, M.D., had just finished his presentation about a compound with the potential to expand the impact of a promising category of cancer therapeutics when he fielded a question from Stephan Stern, Ph.D.